Skip to main navigation
Syndax
  • Home
  • About Us
    • Back
    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Patients & Caregivers
  • Pipeline
    • Back
    • Pipeline
    • Entinostat
    • SNDX-6352
    • SNDX-5613
    • Clinical Trials
    • Publications
    • Compassionate Use
  • Investors
  • Collaboration
  • Join Us
  • Contact
Syndax
Contact Us
  • About
  • Patients & Caregivers
  • Pipeline
  • Investors
  • Collaboration
  • Join Us

Investors

Investors

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
    • Ownership Profile
  • FAQs
  • Contact Us

Press Releases

12.18.20

Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index

12.11.20

Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

12.09.20

Syndax Announces Pricing of Public Offering of Common Stock

12.07.20

Syndax Announces Proposed Public Offering of Common Stock

12.06.20

Syndax Pharmaceuticals Announces Additional Positive Data from Phase 1 Trial of Axatilimab in Patients with cGVHD

11.30.20

Syndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD Experts

11.11.20

Syndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference

11.04.20

Syndax Pharmaceuticals to Present Updated Data from Phase 1 Trial of Axatilimab in cGVHD During Oral Session at the 62nd ASH Annual Meeting

11.02.20

Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update

10.26.20

Syndax to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 2, 2020

09.02.20

Syndax Announces Participation at Three Upcoming Investor Conferences

08.06.20

Syndax Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Shareholder Tools

  • Printed Materials
  • Email Alerts
  • RSS
  • Print
  • Share
  • Search

  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS
© 2021 Syndax | Terms of Use | Privacy Policy | Site Map
  • About Us
  • Pipeline
  • News
  • Investors
  • Collaboration
  • Careers